Science Explorer Back to mapMap
Discussion
Researcher · Teikoku Pharma (United States) · United States

Kunio Tsukamoto

Kunio Tsukamoto publishes mostly in Pharmacology, Genetics and Pharmacology, on topics such as Estrogen and related hormone effects, Cancer therapeutics and mechanisms and Pharmacogenetics and Drug Metabolism.

OpenAlex
World rank
#6,630,675
of 7,710,434 ranked researchers
Rank in United States
#1,539,659
of 1,627,098
Works
15
Citations
28
Citations per work
1.9
h-index
4
i10-index 0Top 94% in Pharmacology (Medicine)
Kunio Tsukamoto

What does Kunio Tsukamoto research?

Kunio Tsukamoto's work is mostly in Biochemistry, Genetics and Molecular Biology (27%), Medicine (21%), Pharmacology, Toxicology and Pharmaceutics (12%).

Life Sciences: 6 works · 39.4% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 27.3% of their workGenetics: 2 works · 12.1% of their workMolecular Biology: 1 works · 9.1% of their workClinical Biochemistry: 1 works · 6.1% of their workPharmacology, Toxicology and Pharmaceutics: 2 works · 12.1% of their workPharmacology: 2 works · 12.1% of their workEverything else: 6 works · 39.4% of their workHealth Sciences: 3 works · 21.2% of their workMedicine: 3 works · 21.2% of their workPharmacology: 2 works · 12.1% of their workOncology: 1 works · 9.1% of their workTHEIR WORKKunio Tsukamoto15works
Life Sciences39%Health Sciences21%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology427.3%
    2. Pharmacology, Toxicology and Pharmaceutics212.1%
  2. Everything else639.4%
    1. Medicine321.2%
  1. 1Pharmacology12% of their works
  2. 2Genetics12% of their works
  3. 3Pharmacology12% of their works
  4. 4Oncology9% of their works
  5. 5Molecular Biology9% of their works
  6. 6Clinical Biochemistry6% of their works

Research topics

Which keywords describe Kunio Tsukamoto's research?

The keywords of their largest research topics: Nuclear Receptors, Estrogen, Receptor, ATP-dependent Transporters, Cytochrome P450, DNA, Multidrug Resistance and Pharmacogenetics.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Nuclear Receptors72 topics
  2. Estrogen41 topic
  3. Receptor41 topic
  4. ATP-dependent Transporters31 topic
  5. Cytochrome P45031 topic
  6. DNA31 topic
  7. Multidrug Resistance31 topic
  8. Pharmacogenetics31 topic
  9. Topoisomerases31 topic
  10. Antibiotic Pharmacokinetics21 topic
  11. Biochemical Genetics21 topic
  12. Critically Ill Patients21 topic
  13. Hormone Therapy21 topic
  14. Metabolic Disorders21 topic
  15. Testosterone21 topic
  16. Deuterium11 topic
  17. Drug Discovery11 topic

Where does Kunio Tsukamoto work?

Kunio Tsukamoto's main affiliation in the publication record is Teikoku Pharma (United States), United States.

How many publications and citations does Kunio Tsukamoto have?

OpenAlex counts 15 works and 28 citations for Kunio Tsukamoto, an h-index of 4, ranking #6,630,675 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kunio Tsukamoto. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.